Ultra‐rapid BioChaperone Lispro improves postprandial blood glucose excursions vs insulin lispro in a 14‐day crossover treatment study in people with type 1 diabetes
Sign Up to like & getrecommendations! Published in 2018 at "Diabetes"
DOI: 10.1111/dom.13442
Abstract: To investigate the safety and efficacy of BioChaperone Lispo (BCLIS), an ultra‐rapid formulation of insulin lispro (LIS) in people with type 1 diabetes. read more here.
Keywords: ultra rapid; biochaperone; people type; insulin lispro ... See more keywords